New Online Casinos Australia 2025: RubyReels Shines as a Premier Gaming Destination

New Online Casinos Australia 2025: RubyReels Shines as a Premier Gaming Destination GlobeNewswire October 25, 2025 Sydney, Australia, Oct. 25, 2025 (GLOBE NEWSWIRE) — As Australia's online gaming scene continues to thrive, RubyReels Casino has emerged as a standout among new online casinos in 2025, offering Australian players a world-class gaming experience backed by cutting-edge […]

DeLeion Capital Highlights BNB Opportunity amid Regulatory Shift and Ecosystem Renewal

San Francisco, CA, Oct. 25, 2025 (GLOBE NEWSWIRE) — Global digital-asset custody and investment firm DeLeion Capital today calls attention to the renewed potential of the Binance ecosystem, anchored by BNB, following the recent presidential pardon of Binance CO-Founder Changpeng Zhao (“CZ”). The firm believes this development marks a pivotal turning point in crypto regulatory

DeLeion Capital Highlights BNB Opportunity amid Regulatory Shift and Ecosystem Renewal

DeLeion Capital Highlights BNB Opportunity amid Regulatory Shift and Ecosystem Renewal GlobeNewswire October 25, 2025 San Francisco, CA, Oct. 25, 2025 (GLOBE NEWSWIRE) — Global digital-asset custody and investment firm DeLeion Capital today calls attention to the renewed potential of the Binance ecosystem, anchored by BNB, following the recent presidential pardon of Binance CO-Founder Changpeng

Avacta presents first preclinical data from dual payload pre|CISION(R) medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

(LSE – AIM:AVCT), LONDON and PHILADELPHIA, Oct. 25, 2025 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, 'Avacta', 'the Company'), a clinical stage biopharmaceutical company developing pre|CISION(R), a tumor-activated oncology delivery platform, today announced the presentation of preclinical data demonstrating its novel first-in-class dual payload pre|CISION(R) technology (AVA6207) at the AACR-NCI-EORTC International Conference on Molecular Targets

Avacta presents first preclinical data from dual payload pre|CISION(R) medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

Avacta presents first preclinical data from dual payload pre|CISION(R) medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and maximize tumor control GlobeNewswire October 25, 2025 LONDON and PHILADELPHIA, Oct. 25, 2025 (GLOBE NEWSWIRE) —

KBR CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds KBR Stockholders of the November 18th Deadline for the Filed Class Action Lawsuit

(NYSE:KBR), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired KBR securities between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon

KBR CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds KBR Stockholders of the November 18th Deadline for the Filed Class Action Lawsuit

KBR CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds KBR Stockholders of the November 18th Deadline for the Filed Class Action Lawsuit GlobeNewswire October 25, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or

JASPER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Jasper Therapeutics Stockholders to Contact the Firm Regarding Filed Class Action

(NASDAQ:JSPR), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jasper (JSPR) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire

JASPER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Jasper Therapeutics Stockholders to Contact the Firm Regarding Filed Class Action

JASPER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Jasper Therapeutics Stockholders to Contact the Firm Regarding Filed Class Action GlobeNewswire October 25, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jasper (JSPR) To Contact Him Directly To Discuss Their Options If you purchased or acquired

FORTINET CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fortinet Stockholders to Contact the Firm Before November 21st

(NASDAQ:FTNT), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fortinet (FTNT) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Fortinet between November 8, 2024 through August 6, 2025 and would like to discuss your legal rights, call Bragar Eagel &

Scroll to Top